Treatable traits in advanced emphysema patients eligible for bronchoscopic lung volume reduction with endobronchial valves.
Saved in:
| Title: | Treatable traits in advanced emphysema patients eligible for bronchoscopic lung volume reduction with endobronchial valves. |
|---|---|
| Authors: | Posthuma R; Department of Research and Development, Ciro+, Horn, the Netherlands; NUTRIM, School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht, the Netherlands; Department of Respiratory Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands. Electronic address: reinposthuma@ciro-horn.nl., van der Molen MC; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases, Groningen, the Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Hartman JE; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases, Groningen, the Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Spruit MA; Department of Research and Development, Ciro+, Horn, the Netherlands; NUTRIM, School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht, the Netherlands; Department of Respiratory Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands., Slebos DJ; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases, Groningen, the Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Vanfleteren LEGW; COPD Center, Sahlgrenska University Medical Hospital and Institute of Medicine, Gothenburg University, Gothenburg, Sweden., Vaes AW; Department of Research and Development, Ciro+, Horn, the Netherlands. |
| Source: | Respiratory medicine [Respir Med] 2024 Apr; Vol. 224, pp. 107558. Date of Electronic Publication: 2024 Feb 17. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
